Patients' characteristics
| . | Value . |
|---|---|
| Number of patients | 21 |
| Sex | |
| Male | 15 |
| Female | 6 |
| Number of allografts | 22 |
| Myelofibrosis | |
| Primary | 13 |
| Secondary | 6 |
| Secondary AML from primary myelofibrosis | 2 |
| Lille score, excluding sAML | |
| Low | 4 |
| Intermediate | 13 |
| High | 2 |
| Cervantes score, excluding sAML | |
| Low | 5 |
| High | 14 |
| Donor | |
| Related | 5 |
| Unrelated | 16 |
| Acute GVHD, % | |
| Grade II-IV | 28 |
| Grade III-IV | 8 |
| Chronic GVHD, % | |
| Overall | 52 |
| Limited | 28 |
| Extensive | 24 |
| . | Value . |
|---|---|
| Number of patients | 21 |
| Sex | |
| Male | 15 |
| Female | 6 |
| Number of allografts | 22 |
| Myelofibrosis | |
| Primary | 13 |
| Secondary | 6 |
| Secondary AML from primary myelofibrosis | 2 |
| Lille score, excluding sAML | |
| Low | 4 |
| Intermediate | 13 |
| High | 2 |
| Cervantes score, excluding sAML | |
| Low | 5 |
| High | 14 |
| Donor | |
| Related | 5 |
| Unrelated | 16 |
| Acute GVHD, % | |
| Grade II-IV | 28 |
| Grade III-IV | 8 |
| Chronic GVHD, % | |
| Overall | 52 |
| Limited | 28 |
| Extensive | 24 |
Median age of the patients: 55 years (range, 32-63 years). Values indicate number of patients except where otherwise indicated.